Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.

Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity. 1994; 19(2):89-98.

View in: PubMed

subject areas

Administration, Oral
Adult
Aged
CD4-Positive T-Lymphocytes
Fatigue
Feeding and Eating Disorders
Female
Humans
Leukocyte Common Antigens
Male
Middle Aged
Multiple Sclerosis
Pilot Projects
Receptors, Interleukin-2
Tacrolimus
Tremor

authors with profiles

John Fung